Two important Akumin updates this week!
1. An update of the pending Alliance acquisition including:
a. Post-closing management composition and director nominees;
b. The filing of the LTM and pro forma financials for Akumin and Alliance (including a slight increase in the pro forma LTM EBITDA to US$213mm from $210mm); and
c. Confirmation that the transaction is expected to close in Q3/21, subject to HSR clearance.
2. The launch of a senior note offering to fund the cash portion of the Alliance acquisition. The offering is being led by Barclays and the syndicate includes JP Morgan Chase, Raymond James and Silicon Valley Bank, among others.
We are very excited about our continued progress towards closing the Alliance Healthcare Services acquisition!
This landmark transaction will bring together two US healthcare leaders in the fields of radiology and oncology with particular expertise in outpatient service delivery - truly transformational yet not yet well-understood (or appreciated) by the market. Please contact me to learn more. R. Jeffrey White LL.B., MBA Director, Corporate Development and Investor Relations Akumin rjwhite@hingemarkets.com
댓글